During August and September 2025 alone, plaintiff attorneys added approximately 486 new cases to the MDL, a pace that shows this litigation is still growing, not slowing down
When should someone on GLP-1 therapy consult a clinician instead of relying on probiotics
Database 2018 , bay003 (2018)
December 2, 2024: Ozempic and Other GLP-1 Lawsuits Reach 1,300 Active Plaintiffs As of December 2, 2024, there are 1,300 pending lawsuits in the consolidated federal lawsuits against manufacturers of GLP-1 drugs such as Ozempic, which is manufactured by Novo Nordisk
Serious acute illness (#3/4 above) may occur in combination with ketoacidosis
Early embryonic lethality caused by targeted disruption of the mouse PHGPx gene